Share Email Print

Proceedings Paper

Gold-mediated drug delivery for improved outcome in chemotherapy
Author(s): C. Yang; B. D. Chithrani
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Nanoparticles can be used to overcome the side effects due to poor distribution of anticancer drugs. Among other NPs, colloidal gold nanoparticles (GNPs) offer the possibility of transporting major quantities of drugs due to their large surface-to volume ratio while confining anticancer drugs as closely as possible to their biological targets through passive and active targeting ensuring limited harmful systemic distribution. In this study, we chose bleomycin (BLM) as the anticancer drug since its therapeutic efficiency is severely limited because of its side effects. Bleomycin was conjugated to GNPs through a thiol bond. The effectiveness of the chemotherapeutic drug, bleomycin, is observed by visualizing DNA double strand breaks and calculating the survival fraction. The action of the drug is known to be in the nucleus and our experiments have shown GNPs in the nucleus along with bleomycin. Use of GNPs to deliver bleomycin increased the therapeutic efficacy of the drug. Having a better understanding of the interaction of GNPs and drugs will establish a more successful NP-based platform for combined therapeutic approach in cancer research since GNPs can be used as radiation dose enhancers.

Paper Details

Date Published: 22 February 2017
PDF: 5 pages
Proc. SPIE 10078, Colloidal Nanoparticles for Biomedical Applications XII, 1007812 (22 February 2017); doi: 10.1117/12.2263227
Show Author Affiliations
C. Yang, Ryerson Univ. (Canada)
B. D. Chithrani, Ryerson Univ. (Canada)
Univ. of Victoria (Canada)

Published in SPIE Proceedings Vol. 10078:
Colloidal Nanoparticles for Biomedical Applications XII
Marek Osiński; Wolfgang J. Parak; Xing-Jie Liang, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?